| |
|
|
|
Millendo Therapeutics Inc.  
|
|
1.575 -0.035 (-0.02%) |
07-14 14:07 |
|
Open: |
1.64 |
Pre close: |
1.61 |
Target:
|
3.32
|
|
High: |
1.64 |
Low: |
1.5508 |
Resistance:
|
2.84
3.64
|
|
Volume: |
274,620 |
Market Cap: |
30M |
Support:
|
1.55
1.29
|
|
|
|
|
|
Technical Analysis |
|
Moving Averages |
MA(5):
|
1.65
 |
MACD |
MACD(12,26):
|
-0.16 |
|
MA(20): |
1.98 |
Signal(12,26,9): |
-0.13 |
|
MA(100): |
3.40 |
Stochastic Oscillator |
%K(14,3):
|
6.20 |
|
MA(250): |
5.84 |
%D(3): |
7.31  |
|
Average Volume(K) |
3-Month: |
154974
|
52-Week |
High:
|
11.07 |
|
10-Days: |
63268 |
Low: |
1.26 |
|
RSI |
RSI(14):
|
38.78 |
Change(%): |
-85.2 |
|
Financials, Statistics and Valuation |
|
EPS |
-3.084 |
Return on Equity (ttm) |
-78.1 |
Shares Out. (M) |
19.00 |
|
EPS Est. Current Year |
0.000 |
Return on Assets (ttm) |
-41.2 |
Shares Float (M) |
12.54 |
|
EPS Est. Next Year |
0.000 |
PEG Ratio |
0.00 |
% Held by Insiders |
11.30 |
|
EPS Est. Next Quarter |
0.000 |
Qtrly Rev. Growth |
0.0 |
% Held by Institutions |
65.47 |
|
Forward EPS |
-3.250 |
Gross Profit (p.s.) |
0.000 |
Shares Short (K) |
755 |
|
Book Value (p.s.) |
2.830 |
EBITDA (p.s.) |
-2.461 |
P/E |
-0.51 |
|
Sales Per Share |
0.000 |
Qtrly Earnings Growth |
0.00 |
P/BV |
0.55 |
|
Profit Margin |
0.00 |
Operating Cash Flow
(M) |
-40.78 |
P/S |
0.00 |
|
Operating Margin |
0.00 |
Levered Free Cash Flow
(M) |
-23.45 |
P/CF |
-0.73 |
|
|
|
|
|
|
